MENU
CABA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Cabaletta Bio (CABA) Earnings Date & Reports
Cabaletta Bio Inc is a late clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies for autoimmune diseases... Show more
A.I. Advisor
published Earnings
CABA is expected to report earnings to fall 6.88% to -31 cents per share on November 05
Q3'26
Est.
$-0.32
Q2'26
Beat
by $0.03
Q1'26
Est.
$-0.39
Q4'25
Beat
by $0.06
Q3'25
Beat
by $0.03
The last earnings report on August 13 showed earnings per share of -34 cents, beating the estimate of -37 cents. With 2.75M shares outstanding, the current market capitalization sits at 530.68M.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information
General Information
a clinical-stage biotechnology company, which engages in the discovery and development of engineered T cell therapies for B cell-mediated autoimmune diseases
Industry Biotechnology
Profile
Details
Industry
N/A
Address
2929 Arch Street
Phone
+1 267 759-3100
Employees
156
Web
https://www.cabalettabio.com